New Bill Aims to Fast-Track Rare Disease Drugs

Millions of families wait years for cures to rare illnesses. Testing new drugs takes too long and costs too much money. Now, lawmakers want to change that system.

A new bipartisan bill cuts red tape for medical trials. It helps biotech firms test treatments with fewer delays. The plan lowers study costs and helps sick patients join trials from home.

Faster trials save lives. They also help smaller drug companies bring treatments to market sooner. This push can boost healthcare innovation and create new opportunities for growth.

Source: CNBC